Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Fitzpatrick

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
BJU International|October 21, 2009
Epidemiology of testicular cancerRustom P Manecksha, John M Fitzpatrick
BJU International|December 13, 2005
Side-effects of treatments for locally advanced prostate cancerKevin M O'Connor, John M Fitzpatrick
BJU International|May 12, 2009
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaRaymond C Rosen, John M Fitzpatrick,
European Urology|August 6, 2013
Taxane mechanisms of action: potential implications for treatment sequencing in metastatic castration-resistant prostate cancerJohn M Fitzpatrick, Ronald de Wit
Current Opinion in Urology|July 2, 2010
The diagnosis and management of complex renal cystsBarry B McGuire, John M Fitzpatrick
BJU International|August 14, 2008
BUF in SicilyJohn M Fitzpatrick, Roger S Kirby
Current Opinion in Urology|July 9, 2009
Biomarkers in renal cell carcinomaBarry B McGuire, John M Fitzpatrick
BJU International|March 2, 2011
Improved survival prospects for patients with castration-resistant prostate cancerRoger S Kirby, John M Fitzpatrick
BJU International|January 27, 2011
Risk stratification for benign prostatic hyperplasia (BPH) treatmentMark Emberton, John M Fitzpatrick, Jon Rees
BJU International|July 22, 2010
Can lifestyle modification lower the risk of prostate cancer?Roger Kirby, Michael Kirby, John M Fitzpatrick
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
BJU International|October 21, 2009
Epidemiology of testicular cancerRustom P Manecksha, John M Fitzpatrick
BJU International|December 13, 2005
Side-effects of treatments for locally advanced prostate cancerKevin M O'Connor, John M Fitzpatrick
BJU International|May 12, 2009
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaRaymond C Rosen, John M Fitzpatrick,
European Urology|August 6, 2013
Taxane mechanisms of action: potential implications for treatment sequencing in metastatic castration-resistant prostate cancerJohn M Fitzpatrick, Ronald de Wit
Current Opinion in Urology|July 2, 2010
The diagnosis and management of complex renal cystsBarry B McGuire, John M Fitzpatrick
BJU International|August 14, 2008
BUF in SicilyJohn M Fitzpatrick, Roger S Kirby
Current Opinion in Urology|July 9, 2009
Biomarkers in renal cell carcinomaBarry B McGuire, John M Fitzpatrick
BJU International|March 2, 2011
Improved survival prospects for patients with castration-resistant prostate cancerRoger S Kirby, John M Fitzpatrick
BJU International|January 27, 2011
Risk stratification for benign prostatic hyperplasia (BPH) treatmentMark Emberton, John M Fitzpatrick, Jon Rees
BJU International|July 22, 2010
Can lifestyle modification lower the risk of prostate cancer?Roger Kirby, Michael Kirby, John M Fitzpatrick
Pageof 18